Chronic diseases like cancer and diabetes were once the preserve of wealthy countries but are now increasingly common in lower-income countries too as populations age and lifestyles change.

New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.

Novartis taps MOOC technology to share chemistry education with the world

Why are some sickle cell disease patients protected from the disease? Learn about our biomedical research in the field.

Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research

How two years in a Novartis lab changed Johnny Castillo’s life.

Three years after discussing how to reuse an old scientific measuring device, Novartis scientists are now testing this idea as part of an innovative research project.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.